Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Sharp Shalini

Over the trailing 90 days, Sharp Shalini (Director at NEUROCRINE BIOSCIENCES INC) bought $240K of stock across 4 companies, per 6 SEC Form 4 transactions.

Role
Director
Companies
NBIX SEPN OGN ONC
Window
Trailing 90 days · 6 transactions · CIK 1377202
Net activity
+$240K ($240K bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
OGNOrganon & Co.1$240K$240K
SEPNSepterna, Inc.1$0
ONCBeOne Medicines Ltd.1$0
NBIXNEUROCRINE BIOSCIENCES INC3$0

Transactions (6)

DateSymbolTypeSharesValueDescription
2026-06-26SEPNBuy15.0K$0Grant, award or other acquisition
2026-06-12OGNBuy17.9K$240KGrant, award or other acquisition
2026-06-11ONCBuy19.0K$0Grant, award or other acquisition
2026-05-27NBIXBuy2.6K$0Grant, award or other acquisition
2026-05-21NBIXSell1.7K$0Exercise or conversion of derivative security
2026-05-21NBIXBuy1.7K$0Exercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Sharp's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free